A Single-arm Exploratory Study of Neoadjuvant Therapy

NCT05527808 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma

Interventions

DRUG: Tislelizumab
DRUG: pemetrexed
DRUG: cis-platemum
DRUG: or carboplatin

Sponsor

Jun Liu